Dr M Lee Pearce Foundation Inc.

The Dr. M. Lee Pearce Foundation operates through deep, multi-year institutional partnerships rather than open grant competitions — making relationship cultivation the single most important strategy for any aspiring grantee. Founded in 1984 by M. Lee Pearce M.D., J.D. (1930–2017), a physician-entrepreneur-attorney who also founded Bank of North America in Fort Lauderdale, the foundation reflects its founder's dual professional identity in every grant it makes. The giving philosophy is captured in the foundation's own guiding question: 'What good is all the medical science in the world in extending life if it is not accompanied by an acceptable quality of life?' Every grant falls into one of two lanes: translational medical research on age-associated chronic diseases, or classical music and opera institutions investing in long-term sustainability.

The grantee roster reveals a strong preference for marquee, nationally recognized institutions over emerging or community-level nonprofits. Anchor relationships with Feinstein Institutes for Medical Research ($700,000 across 3 grants), the Cleveland Orchestra ($600,000 across 3 grants), Washington National Opera ($600,000 across 3 grants), Harvard Medical School ($300,000), the Metropolitan Opera ($200,000), and the University of Miami Frost School of Music ($500,750 across 6 grants) demonstrate that the Pearce Foundation invests in institutions with proven infrastructure and national reputations. The foundation has supported more than 52 organizations globally across its 40-year history.

The most consequential rule for all applicants: the foundation explicitly does not accept unsolicited proposals. This is a hard requirement, not a soft preference. Access to funding requires either a pre-existing relationship with a board member or direct outreach that the foundation itself chooses to pursue. The board is not ceremonial — it includes physician-scientists Dr. Tatjana Rundek (vascular neurology), Dr. Joseph B. Martin (neuroscience, former Harvard Medical School dean), and Dr. Andre Terzic (regenerative medicine, Mayo Clinic) for the medical portfolio, alongside arts leaders Marc A. Scorca (president of Opera America) and Mark Volpe (seasoned classical music executive) for the music portfolio.

For organizations that fit within either pillar, the path to first-time funding typically involves years of relationship-building. The University of Miami Frost School of Music's six-grant, multi-year partnership — spanning music programming and music therapy/brain aging research — represents the foundation's ideal: an institution that bridges both of Dr. Pearce's passions. Organizations that can position their work at the intersection of aging science and cultural vitality are especially well-positioned for consideration.

The Pearce Foundation's annual grantmaking has maintained a consistent range of $1.1M to $2.2M in total giving over the past decade, with grants paid directly to partner organizations ranging from $610,500 (FY2020) to $1.52M (FY2023). This consistency masks the outsized multi-year commitments the foundation makes to anchor partners: across the 18 discrete grants tracked in financial records, the average individual grant was $163,931, with a total of $2.95M disbursed. The foundation's typical grant profile shows a median of $100,000 and a stated range of $2,500 to $150,000 for individual grants — but multi-year partnerships accumulate to considerably larger totals.

Grant size by relationship tier is instructive. Anchor partners receive $500,000–$700,000 over 3–6 grants: Feinstein Institutes ($700,000 across 3 grants for the Quality of Human Life Survey Program), Cleveland Orchestra ($600,000 across 3 grants for Miami Residency), Washington National Opera ($600,000 across 3 grants for Program Support), and University of Miami Frost ($500,750 across 6 grants spanning music therapy and brain aging). First-time grants are considerably smaller — New World Symphony's initial grant was $50,000 — consistent with a relationship model in which amounts increase over time.

Geographically, Florida historically dominates (University of Miami Frost, New World Symphony), followed by Washington D.C. (Washington National Opera), Ohio (Cleveland Orchestra), New York (Metropolitan Opera, Feinstein Institutes/Northwell), and Massachusetts (Harvard Medical School). The 2025 cycle expanded to Texas (Austin Opera, Houston Grand Opera), Maryland (Baltimore Symphony), California (Cal Performances), Kentucky (Louisville Orchestra), New York state (Glimmerglass Festival), Minnesota (Mayo Clinic), and Illinois (Northwestern Bienen School of Music).

The most significant financial development in the foundation's history is the asset increase reported in FY2024: total assets jumped from $36.9M (FY2023) to $174.3M, driven by $138.3M in total revenue — almost certainly a major posthumous estate transfer from founder M. Lee Pearce's business holdings. At $174.3M in assets, the IRS-mandated minimum annual distribution is approximately $8.7M — roughly four to five times the foundation's historical giving levels of $1.1–2.2M per year. Grant seekers in both medical research and classical music should anticipate a likely step-change in grantmaking volume during the 2025–2028 period.

The Pearce Foundation occupies a distinctive position among private foundations: mid-tier assets with a focused dual mandate (aging medicine plus classical music) that no peer foundation replicates exactly. The comparison below uses approximate figures from publicly available records.

The Pearce Foundation's invitation-only model aligns most closely with the Leon Levy Foundation, which similarly combines scientific (neuroscience) and arts philanthropy through relationship-based grantmaking rather than open RFPs. In contrast, the Knight Foundation — Pearce's closest geographic peer in Miami — operates a hybrid model and accepts open applications for many programs, serving a far larger and more diverse grantee field.

The key strategic distinction: Pearce gives larger individual grants to fewer, more prestigious institutions, while foundations like Jerome distribute smaller grants across a wider competitive field. For established medical research centers and major performing arts organizations, Pearce's model offers a path to $100K–$250K+ multi-year partnerships without competing against hundreds of applicants — but the barrier to entry is relationship-based rather than merit-based in the traditional proposal sense.

The 2025 grant cycle is the foundation's most expansive on record. On the music side, six institutions received funding for the first time: Austin Opera, Baltimore Symphony Orchestra (OrchKids program), Cal Performances (Berkeley, CA), Glimmerglass Festival (Apprenticeship and Artist Programs, Cooperstown, NY), Houston Grand Opera, and Louisville Orchestra (In-Harmony Tour). These additions complement ongoing multi-year relationships: Cleveland Orchestra South Florida Residency-Education (2018–2025), Washington National Opera performance and education support (2019–2025), Metropolitan Opera HD Live in Schools (2020–2025) and Radio Broadcast (2018), New World Symphony WALLCAST Sponsorship (2024–2025), and University of Miami Frost School string, orchestra, and Chopin Academy endowments (2018–2024).

On the medical research side, Mayo Clinic was added as a new partner in 2025 for Alzheimer's disease and macular degeneration studies and an Innovation Prize — bringing the foundation's medical portfolio to Harvard Medical School (Q-FASTR, myasthenia gravis, and aging research), Mayo Clinic, Northwell Health Foundation/Feinstein Institutes (Quality of Human Life Survey Program, 2022–2024), and University of Miami Miller School of Medicine (2020–2024).

The dominant background story is the FY2024 asset surge to $174.3M — a posthumous result of founder M. Lee Pearce's death in October 2017 and the eventual transfer of his business assets to the foundation. Michael Carpenter now leads as President and Chairman; Charles Douglas holds Director Emeritus status. No leadership changes beyond this transition are publicly documented.

Rule zero — no unsolicited proposals: The foundation states this explicitly and enforces it consistently. No grant portal exists, no open RFP cycle exists, and no form-based application is available. Approaching this funder without an invitation is counterproductive.

For medical research organizations: Institutional prestige is the primary filter. The foundation funds Feinstein Institutes, Harvard Medical School, Mayo Clinic, and University of Miami Miller School — all tier-one clinical research institutions. Begin by identifying connections between your organization's leadership and board members Dr. Tatjana Rundek (vascular neurology, University of Miami Miller School), Dr. Joseph B. Martin (neuroscience, former Harvard Medical School dean), and Dr. Andre Terzic (regenerative medicine, Mayo Clinic). The foundation now explicitly cites AI applications in medical data analysis as a funding priority — organizations with machine learning components in aging or chronic disease research should emphasize this angle prominently.

For classical music and opera organizations: Study the grantee portfolio before any outreach. The foundation strongly favors: (1) programs with Florida community engagement or touring residency components, modeled on the Cleveland Orchestra Miami Residency; (2) education and professional development for emerging artists, such as the Glimmerglass Apprenticeship or League of American Orchestras Professional Development; (3) technology-enhanced audience access, such as the Metropolitan Opera HD Live in Schools or New World Symphony WALLCAST. Language that invokes 'quality of life,' 'intergenerational engagement,' and 'financial sustainability strategies' aligns directly with the board's stated priorities.

Timing and first contact: The foundation reviews grants annually on a calendar-year cycle with board review occurring in fall or winter. Initial outreach should begin in spring or early summer. Contact Tricia Hopkins (Administrative Director) at info@PearceFoundation.org or (305) 861-7701 with a brief, respectful inquiry identifying your organization and your alignment with the foundation's mission. Marc A. Scorca (Opera America) is a natural professional-network entry point for opera organizations; Dr. Andre Terzic (Mayo Clinic) for medical research institutions.

The 2025 expansion window: The addition of six new music partners in a single grant cycle is unusual for this foundation and signals active interest in broadening the portfolio — likely in anticipation of distributing significantly larger amounts given the FY2024 asset growth. This is a favorable moment for well-aligned organizations to seek introduction.